Thrombolytic Therapy Market Revenue 2024 to 2034
Thrombolytic Therapy Market Revenue 2024 to 2034
The Thrombolytic Therapy Market is projected to grow from USD 4.35 Bn in 2024 to USD 8.24 Bn by 2034, advancing at a CAGR of 6.6%.
Report ID: 10300
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD USD 4.35 Bn
Forecast Year,
USD USD 8.24 Bn
CAGR, 2025 -
6.6%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
Thrombolytic Therapy Market Size Analysis
Thrombolytic Therapy Market Size By Drug 2024 to 2034 (USD )
| Drug | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Alteplase (tPA) | 1.48 | 1.57 | 1.68 | 1.79 | 1.92 | 2.03 | 2.17 | 2.32 | 2.46 | 2.63 | 2.79 |
| Tenecteplase | 1.04 | 1.12 | 1.19 | 1.26 | 1.34 | 1.44 | 1.54 | 1.64 | 1.74 | 1.85 | 1.97 |
| Reteplase | 0.70 | 0.75 | 0.80 | 0.84 | 0.90 | 0.96 | 1.03 | 1.10 | 1.19 | 1.26 | 1.35 |
| Streptokinase | 0.61 | 0.65 | 0.69 | 0.74 | 0.78 | 0.83 | 0.88 | 0.94 | 1.00 | 1.06 | 1.14 |
| Urokinase | 0.52 | 0.55 | 0.59 | 0.63 | 0.67 | 0.72 | 0.76 | 0.81 | 0.87 | 0.93 | 0.99 |
Thrombolytic Therapy Market Size By Indication 2024 to 2034 (USD )
| Indication | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ischemic Stroke | 2.00 | 2.13 | 2.27 | 2.42 | 2.58 | 2.74 | 2.92 | 3.12 | 3.32 | 3.53 | 3.75 |
| Myocardial Infarction | 1.22 | 1.30 | 1.39 | 1.49 | 1.59 | 1.71 | 1.83 | 1.96 | 2.09 | 2.25 | 2.40 |
| PE/DVT | 0.96 | 1.02 | 1.08 | 1.15 | 1.22 | 1.30 | 1.38 | 1.45 | 1.55 | 1.65 | 1.76 |
| Others | 0.17 | 0.18 | 0.20 | 0.21 | 0.22 | 0.24 | 0.25 | 0.27 | 0.29 | 0.31 | 0.33 |
Thrombolytic Therapy Market Size By Route 2024 to 2034 (USD )
| Route | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| IV Bolus | 1.56 | 1.67 | 1.77 | 1.89 | 2.02 | 2.15 | 2.29 | 2.46 | 2.63 | 2.80 | 2.98 |
| IV Infusion | 2.78 | 2.97 | 3.17 | 3.38 | 3.60 | 3.84 | 4.09 | 4.34 | 4.63 | 4.93 | 5.26 |
Thrombolytic Therapy Market Size By End-User 2024 to 2034 (USD )
| End-User | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospitals | 3.04 | 3.25 | 3.46 | 3.70 | 3.95 | 4.21 | 4.49 | 4.79 | 5.12 | 5.47 | 5.83 |
| ASCs/Clinics | 0.87 | 0.93 | 0.99 | 1.05 | 1.11 | 1.19 | 1.26 | 1.34 | 1.43 | 1.52 | 1.62 |
| Others | 0.43 | 0.46 | 0.49 | 0.52 | 0.55 | 0.59 | 0.62 | 0.67 | 0.71 | 0.74 | 0.79 |
Thrombolytic Therapy Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.83 | 1.94 | 2.06 | 2.20 | 2.36 | 2.51 | 2.66 | 2.84 | 3.03 | 3.24 | 3.47 |
| Europe | 1.22 | 1.30 | 1.39 | 1.49 | 1.58 | 1.68 | 1.80 | 1.91 | 2.03 | 2.15 | 2.27 |
| Asia Pacific | 0.96 | 1.02 | 1.09 | 1.16 | 1.23 | 1.32 | 1.41 | 1.51 | 1.61 | 1.72 | 1.85 |
| Latin America | 0.17 | 0.19 | 0.20 | 0.21 | 0.22 | 0.23 | 0.25 | 0.27 | 0.28 | 0.30 | 0.32 |
| Middle East & Africa | 0.17 | 0.19 | 0.20 | 0.21 | 0.23 | 0.24 | 0.26 | 0.27 | 0.29 | 0.31 | 0.33 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
